Skip to content

ABLD · Euronext Paris · ISIN FR001400AHX6

ABL Texcell Diagnostics, Advanced Biological Laboratories

Company news

Presentation of the DeepChek®-HIV Whole Genome Assay at ECCMID 2022

We are pleased to announce a new poster presentation entitled “Evaluation of a commercial assay whole genome HIV-1 using next-generation sequencing” at ECCMID 2022.

Link to the poster presentation.

Please feel free to contact us to get more information.

See all